Acadia Pharmaceuticals | ACAD - Pre Tax Profit

Stock Price
22.54
Daily Change
-0.02 -0.09%
Monthly
0%
Yearly
59.74%
Q2 Forecast
21.53

Acadia Pharmaceuticals reported $26.32M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 26.32M 18.28M Dec/2025
ALKERMES USD 100.74M 4.1M Sep/2025
Alnylam Pharmaceuticals USD 161.14M 77.83M Dec/2025
Biogen USD 557.3M 186.7M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Eisai JPY 22B 7.47B Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
Incyte USD 389.94M 92.37M Dec/2025
J&J USD 4.97B 2.53B Dec/2025
Moderna USD -187M 631M Sep/2025
Neurocrine Biosciences USD 239.4M 52.4M Dec/2025
Pfizer USD 3.33B 290M Sep/2025
Prothena USD -21.58M 15.33M Dec/2025
PTC Therapeutics USD -139.08M 116.01M Dec/2025
Sarepta Therapeutics USD -407.67M 213.63M Dec/2025
Ultragenyx Pharmaceutical USD -128M 51.54M Dec/2025
Vanda Pharmaceuticals USD -22.92M 16.68M Dec/2024
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025